Q4 2024 |
288 |
$42.5B |
+$3.43B |
-$6.34B |
-$2.91B |
SE, APP, TSM, SPOT, CP
|
Restatement |
2/11/2025, 02:15 PM |
Q3 2024 |
289 |
$44.1B |
+$2.77B |
-$3.43B |
-$664M |
CP, SE, IBN, ICLR, TSM
|
13F-HR |
11/4/2024, 03:57 PM |
Q2 2024 |
267 |
$42.3B |
+$6.1B |
-$4.76B |
+$1.34B |
CP, ICLR, IBN, ASML, WCN
|
13F-HR |
7/31/2024, 02:12 PM |
Q1 2024 |
246 |
$42.1B |
+$4.36B |
-$1.92B |
+$2.45B |
CP, ICLR, TEAM, IBN, ASML
|
13F-HR |
4/25/2024, 02:14 PM |
Q4 2023 |
249 |
$36.2B |
+$2.81B |
-$4.48B |
-$1.66B |
CP, TEAM, ICLR, MELI, IBN
|
13F-HR |
1/29/2024, 02:04 PM |
Q3 2023 |
206 |
$34.1B |
+$3.11B |
-$470M |
+$2.64B |
CP, TEAM, ICLR, IBN, AON
|
13F-HR |
10/10/2023, 03:19 PM |
Q2 2023 |
217 |
$33.5B |
+$4.74B |
-$1.13B |
+$3.61B |
CP, AON, IBN, TEAM, ASML
|
13F-HR |
7/14/2023, 12:10 PM |
Q1 2023 |
211 |
$31.3B |
+$2.79B |
-$3.43B |
-$639M |
CPXXXX, TEAM, AON, IBN, MTD
|
13F-HR |
5/15/2023, 05:24 PM |
Q4 2022 |
210 |
$30B |
+$4.61B |
-$2.6B |
+$2.01B |
CPXXXX, AON, MTD, ACN, IBN
|
13F-HR |
2/6/2023, 04:40 PM |
Q3 2022 |
192 |
$27.9B |
+$4.37B |
-$2.14B |
+$2.22B |
CPXXXX, AON, ACN, ASML, EPAM
|
13F-HR |
10/18/2022, 03:00 PM |
Q2 2022 |
199 |
$27.9B |
+$2.61B |
-$2.73B |
-$121M |
CPXXXX, ASML, ACN, AON, ICLR
|
13F-HR |
8/9/2022, 03:41 PM |
Q1 2022 |
198 |
$35.8B |
+$2.03B |
-$3.35B |
-$1.32B |
CPXXXX, ASML, RMD, MTD, ACN
|
13F-HR |
5/6/2022, 03:19 PM |
Q4 2021 |
205 |
$44.4B |
+$1.67B |
-$3.73B |
-$2.06B |
TSM, ASML, SHOP, ACN, MTD
|
13F-HR |
1/26/2022, 03:24 PM |
Q3 2021 |
203 |
$41.8B |
+$3.15B |
-$1.73B |
+$1.43B |
TSM, MELI, SHOP, ASML, RMD
|
13F-HR |
11/1/2021, 06:52 PM |
Q2 2021 |
195 |
$39.4B |
+$5.27B |
-$3.54B |
+$1.73B |
TSM, SHOP, MELI, ASML, CPXXXX
|
13F-HR |
8/4/2021, 07:40 PM |
Q1 2021 |
189 |
$36.5B |
+$1.77B |
-$2.39B |
-$619M |
TSM, HDB, ASML, MELI, CPXXXX
|
13F-HR |
5/13/2021, 10:49 AM |
Q4 2020 |
193 |
$36.8B |
+$3.21B |
-$864M |
+$2.34B |
MELI, TSM, HDB, SHOP, ASML
|
Restatement |
2/23/2021, 02:34 PM |
Q3 2020 |
179 |
$28.5B |
+$2.21B |
-$2.49B |
-$287M |
TSM, MELI, SHOP, CPXXXX, ACN
|
13F-HR |
11/6/2020, 02:58 PM |
Q2 2020 |
180 |
$26.1B |
+$2.38B |
-$54.2M |
+$2.33B |
SHOP, LULU, MELI, TSM, RMD
|
13F-HR |
8/17/2020, 06:38 PM |
Q1 2020 |
180 |
$18.1B |
+$3.51B |
-$813M |
+$2.7B |
TSM, SHOP, LULU, CPXXXX, RMD
|
13F-HR |
5/8/2020, 04:49 PM |
Q4 2019 |
157 |
$18.6B |
+$1.82B |
-$1.44B |
+$378M |
SHOP, TSM, ACN, CPXXXX, HDB
|
Restatement |
2/13/2020, 02:46 PM |
Q3 2019 |
152 |
$16.7B |
+$1.79B |
-$800M |
+$994M |
CB, SHOP, ACN, TSM, HDB
|
13F-HR |
10/25/2019, 01:54 PM |
Q2 2019 |
150 |
$15.9B |
+$1.02B |
-$500M |
+$523M |
CB, SHOP, HDB, MTD, CPXXXX
|
13F-HR |
8/6/2019, 03:37 PM |
Q1 2019 |
142 |
$14.4B |
+$2.15B |
-$517M |
+$1.64B |
CB, SHOP, HDB, ACN, MTD
|
13F-HR |
5/13/2019, 11:43 AM |
Q4 2018 |
79 |
$11.2B |
+$1.6B |
-$1.32M |
+$1.6B |
HDB, SHOP, TSM, CB, CPXXXX
|
13F-HR |
2/11/2019, 02:09 PM |
Q3 2018 |
78 |
$11.2B |
+$1.29B |
-$139M |
+$1.15B |
TSM, SHOP, ACN, CPXXXX, CB
|
13F-HR |
11/1/2018, 03:26 PM |
Q2 2018 |
82 |
$9.67B |
+$2.14B |
-$2.87B |
-$732M |
ACN, HDB, SHOP, TSM, CB
|
Restatement |
9/18/2018, 10:12 AM |
Q1 2018 |
94 |
$10.7B |
+$1.96B |
-$166M |
+$1.79B |
CB, TSM, ACN, HDB, CPXXXX
|
13F-HR |
5/10/2018, 02:51 PM |
Q4 2017 |
96 |
$8.83B |
+$1.24B |
-$515M |
+$730M |
CB, TSM, HDB, ACN, CPXXXX
|
13F-HR |
2/6/2018, 02:08 PM |
Q3 2017 |
87 |
$7.92B |
+$1.18B |
-$17.6M |
+$1.16B |
CB, TSM, HDB, ACN, CPXXXX
|
13F-HR |
11/6/2017, 02:13 PM |
Q2 2017 |
84 |
$6.48B |
+$489M |
-$1.12B |
-$634M |
CB, TSM, HDB, ACN, CPXXXX
|
13F-HR |
8/3/2017, 04:01 PM |
Q1 2017 |
114 |
$9.24B |
+$738M |
-$174M |
+$565M |
CB, TSM, ACN, HDB, CPXXXX
|
13F-HR |
4/11/2017, 12:23 PM |
Q4 2016 |
168 |
$8.28B |
+$609M |
-$638M |
-$28.7M |
CB, TSM, ACN, CPXXXX, CLB
|
13F-HR |
2/1/2017, 03:15 PM |
Q3 2016 |
162 |
$8.77B |
+$3.13B |
-$414M |
+$2.72B |
CB, TSM, CPXXXX, HDB, CTRP
|
13F-HR |
10/31/2016, 11:56 AM |
Q2 2016 |
114 |
$6.27B |
+$545M |
-$284M |
+$261M |
CB, TSM, NVO, CLB, CPXXXX
|
13F-HR |
8/5/2016, 01:03 PM |
Q1 2016 |
115 |
$6.43B |
+$1.78B |
-$60.7M |
+$1.72B |
CB, TSM, NVO, CPXXXX, CLB
|
13F-HR |
5/9/2016, 11:00 AM |
Q4 2015 |
92 |
$4.88B |
+$1.22B |
-$97.8M |
+$1.13B |
TSM, NVO, CTRP, ICLR, CLB
|
13F-HR |
2/9/2016, 06:16 PM |
Q3 2015 |
107 |
$4.01B |
+$524M |
-$187M |
+$337M |
TSM, ACE, NVO, STXXXX, ICLR
|
13F-HR |
11/6/2015, 02:09 PM |
Q2 2015 |
115 |
$4.44B |
+$1.32B |
-$452M |
+$869M |
TSM, NVO, ACE, STXXXX, ASML
|
13F-HR |
8/11/2015, 03:51 PM |
Q1 2015 |
141 |
$4.94B |
+$1.67B |
-$20.6M |
+$1.65B |
TSM, ACE, STXXXX, NVO, PRGO
|
13F-HR |
5/7/2015, 05:13 PM |
Q4 2014 |
114 |
$3.46B |
+$303M |
-$113M |
+$190M |
TSM, ACE, PRGO, STXXXX, ASML
|
13F-HR |
2/9/2015, 03:10 PM |
Q3 2014 |
113 |
$3.24B |
+$315M |
-$49M |
+$266M |
TSM, CPXXXX, CNI, ACE, NVO
|
13F-HR |
11/10/2014, 02:54 PM |
Q2 2014 |
140 |
$3.95B |
+$1.22B |
-$7.38M |
+$1.21B |
TSM, NVO, CPXXXX, ACE, CNI
|
13F-HR |
8/8/2014, 01:14 PM |
Q1 2014 |
137 |
$2.77B |
+$255M |
-$202M |
+$53.5M |
TSM, NVO, ACE, PRGO, CPXXXX
|
13F-HR |
5/8/2014, 04:40 PM |
Q4 2013 |
128 |
$2.71B |
|
|
|
TSM, ACE, PRGO, CNI, CPXXXX
|
Restatement |
2/21/2014, 04:07 PM |